Reprint

Comorbidities and Complications of Cerebral Palsy

Edited by
December 2023
298 pages
  • ISBN978-3-0365-9514-6 (Hardback)
  • ISBN978-3-0365-9515-3 (PDF)

This book is a reprint of the Special Issue Comorbidities and Complications of Cerebral Palsy that was published in

Medicine & Pharmacology
Public Health & Healthcare
Summary

This Special Issue focuses on treating the associated comorbidities and complications of cerebral palsy. Increased prescription of technology means that we are treating some comorbidities of cerebral palsy earlier or even pre-emptively. Increased life expectancy, compared with 20 years ago, means that we are also seeing even later complications of cerebral palsy. However, increased access to intensive medical care at home, non-invasive ventilation, and total parenteral nutrition now exist. There is also greater engagement with the perspectives and expectations of parents/carers and children. As society begins to discuss mental health more openly, we are also starting to recognise the significant two-way associations between disability and mental health. Ethical consultation may be warranted when harm with treatment exceeds the benefit. As we prepare children with cerebral palsy for adulthood, there is more thought and discussion around issues such as pain, mental health, quality of life, independence, and participation. Researchers in the field of cerebral palsy have contributed original articles and reviews which help build our evidence base to guide shared decision making.

Format
  • Hardback
License
© 2022 by the authors; CC BY-NC-ND license
Keywords
mental health; anxiety; depression; cerebral palsy; adolescence; young adults; cerebral palsy; young people; adolescents; unmet need; health services; cerebral palsy; physical therapy; occupational therapy; fracture; bone fragility; mortality; cerebral palsy; epidemiology; mortality; age-adjusted mortality rates; death certificate; medical education; cerebral palsy; severe neurological impairment; scoliosis; shared decision-making; cerebral palsy; respiratory; hospitalisations; antibiotics; Indigenous; inequities; cerebral palsy; cell therapies; stem cells; comorbidities; outcome measures; clinical studies; inflammation; biomarker; cerebral palsy; comorbidity; scoping review; cerebral palsy; co-design; intervention; participation; involvement matrix; public and patient involvement; adolescents; cerebral palsy; early intervention; infant vocalisations; infants; single-subject research design; CP; infant; stress; anxiety; depression; parents; fathers; parent–infant interaction; representations; epilepsy; cerebral palsy; children; neuroimaging; seizure outcome; Sialorrhea; cerebral palsy; submandibular duct relocation; postoperative management; cerebral palsy; ultrasound; piecewise model; muscle volume; cross-sectional area; GMFCS; cerebral palsy; upper limb; sensory function; bimanual intensive functional therapy; hand function; associated impairment; comorbidities; register; children; cerebral palsy; low- and middle-income country; cerebral palsy; hip displacement; hip surveillance; GMFCS; adductor-psoas release; hip reconstruction; guided growth; salvage surgery; cerebral palsy; disability; emotion regulation; depression; anxiety; atropine; cerebral palsy; sialorrhea; pediatric; drooling; sublingual; developmental disorders; neurodevelopmental disorders; n/a